C-XZWCsenescence modulation, phenotypic screening, ATRX
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Discover botanical molecules that modulate senescence.
Joint collaboration between The Estée Lauder Companies and Atropos Therapeutics to explore botanical space for senomodulators.
Joint collaboration agreement announced.
Identify senescence-modulating compounds for aging-related diseases, cancer, and healthspan applications.
Cell-based phenotypic screening platform based on detecting de novo ATRX foci.
Listed by Atropos as a pipeline/platform component on its science-pipeline page.
Develop oncology applications by stimulating senescence-related mechanisms in cancer contexts.
Senescence modulation using compounds identified through Atropos' FATES phenotypic screening platform.
Listed by Atropos as an oncology application/program area on its science-pipeline page.
Develop senescence-targeting drugs for aging-related diseases and healthspan by suppressing senescence-associated biology.
Senescence modulation using compounds identified through Atropos' FATES phenotypic screening platform.
Listed by Atropos as an aging application/program area on its science-pipeline page.